We are live on ! Find out more
CRC

Curi RMB Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 18.93%
This Fund
S&P 500
This Quarter Est. Return
+13.93%
1 Year Est. Return
+18.93%
3 Year Est. Return
+60.65%
5 Year Est. Return
+73.12%
10 Year Est. Return
+312.51%
AUM
$3.27B
AUM Growth
+$351M
Cap. Flow
-$22.9M
Cap. Flow %
-0.7%
Top 10 Hldgs %
17.99%
Holding
534
New
38
Increased
176
Reduced
196
Closed
31

Top Sells

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$8.14M
2
DHR icon
Danaher
DHR
+$4.39M
3
CRS icon
Carpenter Technology
CRS
+$4.38M
4
BILL icon
BILL Holdings
BILL
+$3.97M
5
FIBK icon
First Interstate BancSystem
FIBK
+$3.74M

Sector Composition

Rank Sector Weight
1 Technology 21.63%
2 Financials 19.66%
3 Healthcare 12.62%
4 Industrials 10.92%
5 Consumer Discretionary 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AME icon
26
Ametek
AME
$56.7B
$29.6M 0.91%
179,763
+31,824
+22% +$4.85M
CME icon
27
CME Group
CME
$94.5B
$29.1M 0.89%
138,028
-8,082
-6% -$1.72M
UNH icon
28
UnitedHealth
UNH
$370B
$28.9M 0.88%
54,896
-5,283
-9% -$2.82M
EW icon
29
Edwards Lifesciences
EW
$51B
$28.7M 0.88%
376,452
+1,566
+0.4% +$109K
FICO icon
30
Fair Isaac
FICO
$22.7B
$27.2M 0.83%
23,397
-182
-0.8% -$183K
DIS icon
31
Walt Disney
DIS
$171B
$27M 0.83%
299,467
-6,279
-2% -$554K
KVUE icon
32
Kenvue
KVUE
$36.6B
$25.4M 0.77%
1,177,901
+81,443
+7% +$1.63M
INTU icon
33
Intuit
INTU
$87.9B
$25.1M 0.77%
40,144
-1,405
-3% -$775K
MKTX icon
34
MarketAxess Holdings
MKTX
$5.71B
$24.9M 0.76%
85,108
-7,411
-8% -$1.79M
ACN icon
35
Accenture
ACN
$101B
$23.8M 0.73%
67,936
-1,503
-2% -$485K
UNP icon
36
Union Pacific
UNP
$174B
$23.6M 0.72%
95,880
-3,230
-3% -$710K
WST icon
37
West Pharmaceutical
WST
$24.3B
$23.2M 0.71%
66,002
-1,419
-2% -$502K
EXP icon
38
Eagle Materials
EXP
$6.53B
$23.2M 0.71%
114,512
+357
+0.3% +$62.8K
CDW icon
39
CDW
CDW
$19.1B
$23M 0.7%
101,341
-13,382
-12% -$2.84M
FBIN icon
40
Fortune Brands Innovations
FBIN
$6.33B
$23M 0.7%
302,165
-5,178
-2% -$341K
EGP icon
41
EastGroup Properties
EGP
$11B
$23M 0.7%
125,320
+1,500
+1% +$256K
CW icon
42
Curtiss-Wright
CW
$27.8B
$22.9M 0.7%
102,742
+848
+0.8% +$177K
AMT icon
43
American Tower
AMT
$80.5B
$22.8M 0.7%
105,682
-3,741
-3% -$707K
SCHD icon
44
Schwab US Dividend Equity ETF
SCHD
$104B
$22.7M 0.69%
894,900
-49,176
-5% -$1.17M
AVY icon
45
Avery Dennison
AVY
$13.2B
$22.4M 0.68%
110,855
-2,385
-2% -$446K
CB icon
46
Chubb
CB
$134B
$22.2M 0.68%
98,192
-3,456
-3% -$756K
ITW icon
47
Illinois Tool Works
ITW
$83.7B
$21.7M 0.66%
82,759
-2,265
-3% -$543K
SYK icon
48
Stryker
SYK
$128B
$21.4M 0.65%
71,366
-1,996
-3% -$560K
MS icon
49
Morgan Stanley
MS
$341B
$21.3M 0.65%
228,108
-5,939
-3% -$475K
EFA icon
50
iShares MSCI EAFE ETF
EFA
$79.1B
$20.3M 0.62%
269,314
+10,216
+4% +$722K

Similar funds

Curi RMB Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Curi RMB Capital held 534 positions worth $3.27B, up 12% from $2.92B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Curi RMB Capital's Q4 2023 filing shows 38 new, 176 increased, 196 reduced and 31 closed positions. Its largest new stake was iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036: 186,293 shares worth $5.66M. The largest sale was Synopsys, an estimated $8.14M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Curi RMB Capital's largest Q4 2023 buy was iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036: 186,293 shares worth $5.66M.
  • Curi RMB Capital added most to Ametek in Q4 2023, an estimated $4.85M increase.
  • Curi RMB Capital's biggest Q4 2023 reduction was Synopsys, cutting an estimated $8.14M.
  • Curi RMB Capital fully exited BILL Holdings in Q4 2023, selling an estimated $3.97M.
  • Curi RMB Capital's ten largest holdings make up 18% of its $3.27B portfolio in Q4 2023.
  • Curi RMB Capital opened 38 new positions and closed 31 in Q4 2023.
  • Curi RMB Capital's portfolio value rose 12% quarter-over-quarter to $3.27B.

Based on Curi RMB Capital's 13F filing for Q4 2023, filed 14 Feb 2024.